Importantly, the ability of the T cells to recover from exhaustion has been shown through administration of anti-PD-1 Abs that have correlated with reduced tumor burden for certain human tumors and even EBV-induced lymphomas (23, 48, 50, 104, 105). Here, PDCD1 is linked to lymphoma.